| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.011 | 0.8 |